Edition:
United Kingdom

Dr. Lal PathLabs Ltd (DLPA.NS)

DLPA.NS on National Stock Exchange of India

934.90INR
11:10am BST
Change (% chg)

Rs-25.25 (-2.63%)
Prev Close
Rs960.15
Open
Rs967.35
Day's High
Rs975.90
Day's Low
Rs915.50
Volume
43,858
Avg. Vol
103,612
52-wk High
Rs1,122.00
52-wk Low
Rs723.05

Latest Key Developments (Source: Significant Developments)

Dr. Lal Pathlabs March-qtr Consol Profit Rises
Monday, 14 May 2018 

May 14 (Reuters) - Dr. Lal PathLabs Ltd ::RECOMMENDED DIVIDEND OF 3 RUPEES PER SHARE.MARCH QUARTER CONSOL PROFIT 401 MILLION RUPEES VERSUS PROFIT 314 MILLION RUPEES YEAR AGO.MARCH QUARTER CONSOL REVENUE FROM OPERATIONS 2.67 BILLION RUPEES VERSUS 2.20 BILLION RUPEES YEAR AGO.  Full Article

Dr.Lal Pathlabs Says NCLT Ordered Meetings of Shareholder, Unsecured Creditors For Amalgamation Scheme With Delta Ria And Pathology​​
Friday, 29 Dec 2017 

Dec 29 (Reuters) - Dr. Lal Pathlabs Ltd ::NCLT ORDERED MEETINGS OF SHAREHOLDERS, UNSECURED CREDITORS TO APPROVE SCHEME OF AMALGAMATION BETWEEN CO & DELTA RIA AND PATHOLOGY​.  Full Article

Dr. Lal Pathlabs Says Unit Approves Acquisition Of Satya Pathology And Diagnostic Centre
Tuesday, 12 Dec 2017 

Dec 12 (Reuters) - Dr. Lal Pathlabs Ltd ::SAYS UNIT APPROVES ACQUISITION OF SATYA PATHOLOGY AND DIAGNOSTIC CENTRE.SAYS COST OF ACQUISITION NOT EXCEEDING 20 MILLION RUPEES.  Full Article

India's Dr. Lal Pathlabs Sept-qtr profit falls
Thursday, 9 Nov 2017 

Nov 9 (Reuters) - Dr. Lal Pathlabs Ltd ::Sept quarter profit 502 million rupees versus 528 million rupees year ago.Sept quarter revenue from operations 2.69 billion rupees versus 2.53 billion rupees year ago.Declared interim dividend of 1.50 rupees per share.  Full Article